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Introduction
The majority of acute asthma exacerbations follow upper
respiratory infections, and most are rhinovirus induced.
The pathways by which a rhinovirus infection may lead to
asthma development are still under scrutiny, but the role
of bronchial epithelium in driving this mechanism has
been considered of great importance. It has been shown
that the epithelial derived cytokines IL25, IL33 and TSLP
are upregulated in bronchial asthma and could be further
induced by virus infection. We hypothesise that such cyto-
kines might influence Th2 cell differentiation in the con-
text of rhinovirus infection.
Methods
Beas2B cells were infected with rhinovirus 1b (1MOI) or
incubated with unifected Hela lysates and the superna-
tants were harvested 24 hours later. CD4+ T naive cells
were isolated from CD Leukocyte Cone (buffy coat) and
expanded for 12 days in the presence of anti-CD2, -CD3,
-CD28 and IL2 stimulation. Th2 cells were also expanded
out of the CD4+ T naive cells, in the presence of anti-
CD2, -CD3, -CD28, -IL12 and IL4 stimulation. The
already expanded Th0 cells were put into culture alone,
in the presence of IL33, IL25 or TSLP (10 ng/ml) or with
the supernatants from infected or uninfected cells above
(4:1) for 12 more days. On Day 2, Day 6 and Day 12 of co
culture intracellular levels of IFNg, IL13, IL4 and FOXP3
were assessed by FACS.
Results
On Day 12 of culture, IL13 levels were elevated in virus
infected supernatant, IL33 and IL25 conditions at 10.5,
33.2, and 21.5 per cent in comparison to 2.45, 1.76 and
1.45 per cent on Th0 cells alone or in the presence of
uninfected supernatants or TSLP. IL4 levels followed simi-
lar patterns at lower levels. The positive control Th2 cells
express IL13 at 76.6 per cent and IL4 at 67.4 per cent. In
the same conditions (virus, IL33 & IL25) trends for reduc-
tions in IFNg positivity were observed, decreasing progres-
sively from Day 2 through Day 6 to Day 12, while levels of
expression of FOXP3 remained relatively constant. IL13,
IFNg and FOXP3 expression was not greatly different
between the three timepoints in any other condition
studied.
Conclusion
Rhinovirus 1b infected bronchial epithelial cell superna-
tants, IL33 and IL25 promote Th0 cells to differentiate
towards a Th2 phenotype and away from a Th1 pheno-
type during 12 days of co culture. This model of co cul-
ture might be helpful in investigating the role of the
novel IL25, IL33 and TSLP in asthma development and
exacerbation.
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